-
公开(公告)号：US20240181900A1
公开(公告)日：2024-06-06
申请号：US18069497
申请日：2022-12-21
Inventor： Andrew P. FOOTE , Daniel COSTINETT
IPC: B60L53/122 , H02J50/10
CPC classification number: B60L53/122 , H02J50/10
Abstract: Devices, systems, and methods related to wireless power transfer for vehicles can include a wireless power transfer assembly which may be coupled with the vehicle chassis. The assembly can include a shielding body, and a power coil assembly arranged on one side of the shielding body for wireless power transfer. The assembly can include a capacitor bank assembly for providing capacitance for wireless power transfer. The capacitor bank assembly can be arranged on an opposite side of the shielding body, and can include at least one capacitor bank having at least one compression plate and a number of capacitors connected in series via a bus bar assembly. The number of capacitors of the at least one capacitor bank can be arranged between the corresponding at least one compression plate and the shielding body, and the at least one compression plate can be secured with the shielding body for clamping.
-
公开(公告)号：US20240156765A1
公开(公告)日：2024-05-16
申请号：US18420262
申请日：2024-01-23
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
Inventor： Monica M. JABLONSKI
IPC: A61K31/197 , A61K9/00 , A61K9/113 , A61P27/06
CPC classification number: A61K31/197 , A61K9/0048 , A61K9/113 , A61P27/06
Abstract: This invention is directed to a method of preventing ocular neurodegeneration in a subject in need thereof.
-
13.发明公开
公开(公告)号：US20240029963A1
公开(公告)日：2024-01-25
申请号：US18449245
申请日：2023-08-14
Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION
Inventor： Nathan G. BRADY , Barry D. BRUCE
CPC classification number: H01G9/2059 , H01G9/2027 , H10K71/12 , H10K85/761
Abstract: Amphiphilic co-polymer lipid particle has a core comprising a chlorophyll pigment-protein complex or a bacteriochlorophyll pigment-protein complex within an annulus of membrane lipids, and an outermost layer of amphiphilic co-polymer surrounding an outermost surface of the membrane lipids. Such lipid particles are made by isolating photosynthetic membrane to form isolated photosynthetic membrane, adjusting the chlorophyll concentration of the isolated photosynthetic membrane, and solubilizing the isolated photosynthetic membranes in an amphiphilic co-polymer for a preselected time period that allows amphiphilic co-polymer lipid particles to form. The amphiphilic co-polymer lipid particles form a layer between a cathode and an anode in a photo-electrical energy generating device, and methods of making the same, including a layer of detergent micelles encapsulating lipid proteins rather than amphiphilic co-polymer lipid particles.
-
公开(公告)号：USD1011849S1
公开(公告)日：2024-01-23
申请号：US29786908
申请日：2021-06-03
Applicant: University of Tennessee Research Foundation
Designer： Parker Michael Alperin , Charles William Beasley , Timothy S Clements , Corbin Matthew Day , Tyler James Sheffield
Abstract: FIG. 1 is a perspective view of a chemical roller head core;
FIG. 2 is a front view thereof;
FIG. 3 is a rear view thereof;
FIG. 4 is a rightside view thereof;
FIG. 5 is a leftside view thereof;
FIG. 6 is a top view thereof;
FIG. 7 is a bottom view thereof; and,
FIG. 8 is a cross-sectional view thereof.
The broken lines in the drawings illustrate portions of the chemical roller head core that form no part of the claimed design.
-
公开(公告)号：US20230365740A1
公开(公告)日：2023-11-16
申请号：US18139768
申请日：2023-04-26
Applicant: The Regents of the University of California , University of Tennessee Research Foundation
Inventor： Charles M. Cai , Yun-Yan Wang , Arthur Ragauskas
IPC: C08G18/64 , C08G18/76 , C08G18/67 , C08G18/32 , C08G18/48 , C08G18/65 , C08G18/40 , C08G18/08 , C08G18/24
CPC classification number: C08G18/6492 , C08G18/7671 , C08G18/675 , C08G18/3206 , C08G18/48 , C08G18/6511 , C08G18/4081 , C08G18/0842 , C08G18/246
Abstract: The invention provides a method of production of biogenic lignin-based polyurethane having soft-segments from the co-polymerization of an organosolv lignin or other low molecular weight lignin and a monomeric polyol. The invention also provides polyurethanes having unique and beneficial properties.
-
16.发明授权
公开(公告)号：US11802357B2
公开(公告)日：2023-10-31
申请号：US16566593
申请日：2019-09-10
Inventor： Hicham Kheir Ghossein , Lonnie J. Love , Uday Kumar Vaidya
CPC classification number: D04H1/736 , C01B32/05 , D10B2101/12
Abstract: The present subject matter relates to systems, devices, and methods of enhancing carbon fiber dispersion in wet-laid nonwovens. A quantity of fibers is deposited in a medium, and each of one or more stirring elements is moved in a pattern to mechanically agitate the medium. In some embodiments, moving each of the one or more stirring elements includes moving the one or more stirring elements in complementary patterns to induce a chaotic advection current within the medium.
-
公开(公告)号：US11723738B2
公开(公告)日：2023-08-15
申请号：US15804146
申请日：2017-11-06
Inventor： Katherine E. Riojas , Robert J. Webster , Daniel Caleb Rucker , Kaitlin Oliver Butler , Ryan Ponten
CPC classification number: A61B34/72 , A61B1/0052 , A61B1/0055 , A61B1/0057 , A61B34/30 , A61B34/32 , A61M25/0147 , A61B1/05 , A61B2034/301 , A61B2034/306 , A61M25/0054 , A61M25/0113 , A61M25/0136 , A61M25/0138 , A61M2025/0004 , A61M2025/006 , A61M2025/015 , A61M2205/0266
Abstract: A small diameter surgical tool implements an agonist-antagonist deflectable joint. The deflectable joint is an actuatable bendable structure that uses push-pull, agonist-antagonist action of a pair of nested tubes to actuate the joint. The tubes are designed to have non-central, offset neutral axes, and they are fixed together at locations distal to the deflectable joint, such as at their distal ends. Axial translations of the tubes relative to each other causes a push-pull, agonist-antagonist action between the tubes, which causes the deflectable joint to bend. In one implementation, a deflectable joint can be created in nested tubes by configuring radial portions of the tube sidewalls extending along the joint to have an axial region of reduced stiffness. As a result, axial agonist-antagonist motion between the tubes can cause bending of the deflectable joint.
-
公开(公告)号：US11648234B2
公开(公告)日：2023-05-16
申请号：US17007143
申请日：2020-08-31
Applicant: University of Tennessee Research Foundation
Inventor： Ramesh Narayanan , Duane D. Miller , Thamarai Ponnusamy , Dong-Jin Hwang , Yali He
IPC: A61K31/4164 , A61K31/40 , A61K31/415 , A61P35/00 , A61K31/4196 , A61K31/4439 , A61K31/5375
CPC classification number: A61K31/4164 , A61K31/40 , A61K31/415 , A61K31/4196 , A61K31/4439 , A61K31/5375 , A61P35/00
Abstract: This invention is directed to selective androgen receptor degrader (SARD) compounds pharmaceutical compositions and uses thereof in treating early prostate cancer, prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.
-
公开(公告)号：US20230146829A1
公开(公告)日：2023-05-11
申请号：US17894482
申请日：2022-08-24
Applicant: University of Tennessee Research Foundation
Inventor： Ramesh Narayanan , Thamarai Ponnusamy , Duane D. Miller , Yali He , Dong-Jin Hwang
IPC: A61K31/404 , A61K31/4245 , A61K31/416 , A61K31/4439 , A61K31/422 , A61K31/4188 , A61K31/415 , A61K31/4192
CPC classification number: A61K31/404 , A61K31/4245 , A61K31/416 , A61K31/4439 , A61K31/422 , A61K31/4188 , A61K31/415 , A61K31/4192
Abstract: This invention is directed to selective androgen receptor degrader (SARD) compounds including heterocyclic rings and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, androgenic alopecia or other hyperandrogenic dermal diseases, Kennedy's disease, amyotrophic lateral sclerosis (ALS), abdominal aortic aneurysm (AAA), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (AR-FL) including pathogenic or resistance mutations, AR-splice variants (AR-SV), and pathogenic polyglutamine (polyQ) polymorphisms of AR in a subject.
-
公开(公告)号：US20230115515A1
公开(公告)日：2023-04-13
申请号：US17957539
申请日：2022-09-30
Applicant: University of Tennessee Research Foundation
Inventor： Ramesh Narayanan , Duane D. Miller , Yali He , Thamarai Ponnusamy , Dong-Jin Hwang
IPC: A61K31/415 , A61K31/4439 , A61K31/517 , A61K31/4192 , A61K31/506 , A61K31/422 , A61P35/00
Abstract: This invention relates to pyrazolylpropanamide compounds and uses thereof for treatment of prostate cancer, advanced prostate cancer, refractory prostate cancer, AR overexpressing prostate cancer, castration-resistant prostate cancer, castration-sensitive prostate cancer, AR-V7 expressing prostate cancer, or d567ES expressing prostate cancer, darolutamide resistant prostate cancer, enzalutamide resistant prostate cancer, apalutamide resistant prostate cancer, or abiraterone resistant prostate cancer.
